Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-11-18
2010-12-14
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S235200, C514S235800
Reexamination Certificate
active
07851466
ABSTRACT:
This invention features pyrimidine compounds of formula (I):aryl, or heteroaryl; each of R2and R4, independently, is Rc, halogen, nitro, cyano, isothionitro, SRc, or ORc; or R2and R4, taken together, is carbonyl; R3is Rc, alkenyl, alkynyl, ORc, OC(O)Rc, SO2Rc, S(O)Rc, S(O2)NRcRd, SRc, NRcRd, NRcCORd, NRcC(O)ORd, NRcC(O)NRcRd, NRcSO2Rd, CORc, C(O)ORc, or C(O)NRcRd; R5is H or alkyl; n is 0, 1, 2, 3, 4, 5, or 6; X is O, S, S(O), S(O2), or NRc; Y is a covalent bond, CH2, C(O), C═N—Rc, C═N—ORc, C═N—SRc, O, S, S(O), S(O2), or NRc; Z is N or CH; one of U and V is N, and the other is CRc; and W is O, S, S(O), S(O2), NRc, or NC(O)Rc; in which each of Raand Rb, independently, is H, alkyl, aryl, heteroaryl; and each of Rcand Rd, independently, is H, alkyl, aryl, heteroaryl, cyclyl, heterocyclyl, or alkylcarbonyl.The featured compounds inhibit the production of IL-12, IL-23 and IL-27 and are useful for treating disorders associated with IL-12, IL-23 and IL-27 overproduction or misregulation, such as inflammatory and immune disorders.
REFERENCES:
patent: 6660733 (2003-12-01), Sun et al.
patent: 6858606 (2005-02-01), Sun et al.
patent: 6958332 (2005-10-01), Sun et al.
patent: 7045517 (2006-05-01), Ono et al.
patent: 7067514 (2006-06-01), Ono et al.
patent: 7122665 (2006-10-01), Sun et al.
patent: 7338951 (2008-03-01), Ono et al.
patent: 7470681 (2008-12-01), Sun et al.
patent: 7470685 (2008-12-01), Sun et al.
patent: 2003/0114446 (2003-06-01), Sun et al.
patent: 2003/0139403 (2003-07-01), Ono et al.
patent: 2005/0250770 (2005-11-01), Ono et al.
patent: 2005/0250787 (2005-11-01), Sun et al.
patent: 2006/0025409 (2006-02-01), Ono et al.
patent: 2006/0030560 (2006-02-01), Sun et al.
patent: 2006/0063739 (2006-03-01), Sun et al.
patent: 2006/0122209 (2006-06-01), Zhang et al.
patent: 2006/0223996 (2006-10-01), Sun et al.
patent: 2007/0027151 (2007-02-01), Sun et al.
patent: WO-00/62778 (2000-10-01), None
patent: WO-00/78757 (2000-12-01), None
Vippagunta et al., Crystalline solids, 2001, Advanced Drug Delivery Reviews, 48, pp. 3 and 18.
Mandred E. Wolff, Burger's Medicinal Chemistry and Drug Discovery, 1995, ImmunoPharmaceutics, Inc., Fifth Edition, vol. I: Principles and Practice, pp. 975-977.
Vosse et al., Genetic variations in the interleukin-12/interleukin-23 receptor (Beta1) chain, and implications for IL-12 and IL-23 receptor structure and function, 2003, Immunogenetics, 54:817-829.
Gately et al., Annu. Rev. Immunol. 1998, 16:495-521.
International Search Report and Written Opinion for International Application No. PCT/US05/41928.
Hsia Albert Y.
Lu Rongzhen
Wada Yumiko
Bianchi Kristin
Edwards Angell Palmer & & Dodge LLP
Hsi Jeffrey D.
Saeed Kamal A
Synta Pharmaceuticals Corp.
LandOfFree
Pyrimidine compounds and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrimidine compounds and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidine compounds and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4230264